Literature DB >> 11259523

Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates.

D R Bachvarov1, S Houle, M Bachvarova, J Bouthillier, A Adam, F Marceau.   

Abstract

Agonist-induced endocytosis and/or down-regulation have been evaluated using green fluorescent protein (GFP) conjugates of the rabbit bradykinin (BK) B2 receptor (B2R). COS-1 cells transiently transfected with vectors coding for either of two rabbit B2R fluorescent variants, B2R-GFP and B2R-GFP DeltaS/T (with previously identified Ser/Thr phosphorylation sites in the C-terminal tail mutated to Ala), exhibited specific and saturable binding (K(D) in the lower nM range). The acute addition of BK (10-100 nM) to HEK 293 cells stably expressing B2R-GFP in the presence of cycloheximide was rapidly followed by translocation of the surface receptors into the cells, with essentially complete recycling of the surface receptors in 1 to 3 h (confocal microscopy, cell fractionation). Adding captopril to inhibit angiotensin I-converting enzyme activity increased the half-life of BK in the culture medium (enzyme immunoassay) and, accordingly, promoted B2R-GFP internalization for at least 3 h. However, agonist-induced down-regulation was not observed under conditions optimal for endocytosis (microscopy, immunoblot using anti-GFP antibodies). In contrast, B2R-GFP was partially degraded following a short treatment of cells with trypsin. B2R-GFP internalized following agonist treatment was colocalized with fluorescent transferrin, supporting translocation of the receptor to recycling endosomes. B2R-GFP DeltaS/T failed to translocate into the cells following treatment with BK, but exhibited at baseline an altered subcellular distribution relative to B2R-GFP. The agonist BK promotes B(2)R receptor endocytosis followed by recycling to the cell surface, but does not promote receptor down-regulation in the heterologous system that we used here. Digestion initiated by extracellular proteases may be involved in pathological B2R down-regulation, as suggested by the simulation involving trypsin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259523

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

2.  Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.

Authors:  Albert Adam; Nicolas Montpas; David Keire; Anik Désormeaux; Nancy J Brown; François Marceau; Benjamin Westenberger
Journal:  Biomaterials       Date:  2010-04-27       Impact factor: 12.479

3.  Heterologous downregulation of vasopressin type 2 receptor is induced by transferrin.

Authors:  Richard Bouley; Paula Nunes; Billy Andriopoulos; Margaret McLaughlin; Matthew J Webber; Herbert Y Lin; Jodie L Babitt; Thomas J Gardella; Dennis A Ausiello; Dennis Brown
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-12

4.  Discrepancy between fluorescence correlation spectroscopy and fluorescence recovery after photobleaching diffusion measurements of G-protein-coupled receptors.

Authors:  Rhodora Cristina Calizo; Suzanne Scarlata
Journal:  Anal Biochem       Date:  2013-06-07       Impact factor: 3.365

5.  Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences.

Authors:  Bruno D Cerrato; Oscar A Carretero; Brana Janic; Hernán E Grecco; Mariela M Gironacci
Journal:  Hypertension       Date:  2016-08-22       Impact factor: 10.190

6.  Absence of ligand-induced regulation of kinin receptor expression in the rabbit.

Authors:  T Sabourin; K Guay; S Houle; J Bouthillier; D R Bachvarov; A Adam; F Marceau
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 7.  Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

Authors:  Amaly Nokkari; Hadi Abou-El-Hassan; Yehia Mechref; Stefania Mondello; Mark S Kindy; Ayad A Jaffa; Firas Kobeissy
Journal:  Prog Neurobiol       Date:  2018-01-31       Impact factor: 11.685

8.  Wortmannin alters the intracellular trafficking of the bradykinin B2 receptor: role of phosphoinositide 3-kinase and Rab5.

Authors:  Steeve Houle; François Marceau
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

9.  Bradykinin potentiation by ACE inhibitors: a matter of metabolism.

Authors:  Beril Tom; Andreas Dendorfer; René de Vries; Pramod R Saxena; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

10.  Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme.

Authors:  Enrico Malito; Luis A Ralat; Marika Manolopoulou; Julie L Tsay; Natasha L Wadlington; Wei-Jen Tang
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.